Articles | Volume 6, issue 4
https://doi.org/10.5194/jbji-6-85-2021
https://doi.org/10.5194/jbji-6-85-2021
Brief report
 | 
27 Jan 2021
Brief report |  | 27 Jan 2021

Fluorescent tetracycline bone labeling as an intraoperative tool to debride necrotic bone during septic hip revision: a preliminary case series

Ernesto Muñoz-Mahamud, Jenaro Ángel Fernández-Valencia, Andreu Combalia, Laura Morata, and Álex Soriano

Viewed

Total article views: 1,048 (including HTML, PDF, and XML)
HTML PDF XML Total Supplement BibTeX EndNote
762 253 33 1,048 303 30 33
  • HTML: 762
  • PDF: 253
  • XML: 33
  • Total: 1,048
  • Supplement: 303
  • BibTeX: 30
  • EndNote: 33
Views and downloads (calculated since 27 Jan 2021)
Cumulative views and downloads (calculated since 27 Jan 2021)

Viewed (geographical distribution)

Total article views: 997 (including HTML, PDF, and XML) Thereof 995 with geography defined and 2 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 

Cited

Latest update: 24 Apr 2024
Download
Short summary
A plausible cause of persistent infection after septic hip revision may be the presence of nonviable osteomyelitic bone. We present our initial experience in hip revision for chronic infection in which fluorescent tetracycline bone labeling was used as an additional aid to provide a visual index of surgical bone debridement. In the present series, the use of this technique successfully aided the surgeon to detect the presence of nonviable bone.